Abstract Details

Title Headache Apps Found in the Commercial Marketplace: A Systematic Analysis of Features and Characteristics

Topic Headache

Presentation(s) P1 - Poster Session 1 (9:00 AM-5:00 PM)

Poster/Presentation
Number 202

Objective

To assess characteristics and features of commercial headache apps using the Mobile Health Index and Navigation Database (MIND).

Background

There is increasing interest in the use of mobile health (mHealth) tools to supplement clinical care. The MIND database, a publicly accessible digital app library developed by the Division of Digital Psychiatry at BIDMC, consists of apps rated using 105 objective questions based on five classes within the APA's app evaluation model (Accessibility, Privacy & Security, Clinical Foundation, Engagement Style, and Interoperability), to provide the public an overview of apps across a variety of supported conditions.

Design/Methods Trained app raters entered into the MIND database a total of 48 commercially-available headache apps from the iOS and Google App Stores based on predefined search criteria. Frequency of the characteristics of headache apps were evaluated against a control group (non headache-related apps matched for platforms available and cost) using z-proportion tests to reveal distinguishing features of headache apps.

Results The most common features of headache apps were symptom tracking (n = 32), medication tracking (n = 30), and journaling (n = 16). Additional prominent functionalities include the options to export/email data (n= 25) and direct connection with providers (n = 7). Characteristics lacking are HIPAA compliance (n = 1), evidence-based feasibility/efficacy studies (n=3), and crisis management tools (n = 0).

Conclusions The primary use of commercially existing headache apps are to help users track potential triggers and symptoms and share their data with clinicians. Thus headache apps have potential to provide insight to providers in understanding patient histories and effectiveness of treatments (i.e. medication). Limitations to clinical implementation remain due to lack of crisis management and clinical support studies. HIPAA compliance, which while not mandated for commercial apps, is also becoming a necessary consideration because of increasing privacy regulations requiring protection of personal health information.

Authors/Disclosures
Ananya Sahu, Other PRESENTER	Ms. Sahu has nothing to disclose.
Leslie Yao	Ms. Yao has nothing to disclose.
	No disclosure on file
Mia Soviero	Miss Soviero has nothing to disclose.
Quazi I. Hossain	Mr. Hossain has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mia T. Minen, MD, FAAN (NYULMC Neurology)	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .

��ɫ��

��ɫ��